Celgene antitrust probe closed by Brazil's CADE
MLex Summary: A Brazilian investigation into US pharmaceutical company Celgene for allegedly creating barriers to competition, foreclosing the market and abusing its intellectual property rights in the medicines market has been...To view the full article, register now.
Already a subscriber? Click here to view full article